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A quantitative LC-ESI single quadrupole MS method for the determination of cortisol (F), 
cortisone (E), prednisolone (PL), and prednisone (PN) in bovine urine has been developed and 
validated. After addingflumethasone as internal standard, the samples were subjected tofiltration, 
deconjugation, and solid-phase extraction, while the chromatographic separation was achieved 
using a Restek Ultra II Allure Biphenyl column with isocratic mobile phase. The analytes were 
detected after negative electrospray ionization using SIM mode. In order to obtain spectra with 
maximum intensities of at least one of the three characteristic ions, (Mþformate) , (M—H), and 
[(M—H) - CH20]~, an individual optimization of MS parameters for each corticosteroid was set 
up. MS data was acquired in the three-ion selected monitoring mode and the ion ratios between 
chosen diagnostic ions were used in order to increase the specificity. Calibration graphs were linear 
and the intra-day and intermediate precision was estimated as RSD values which were less than 17%. 
For F and E, obtained values indicated negligible absolute matrix effects (10
3
% and 98%, 
respectively). The method was applied to real samples, and basal levels ofFandE were preliminarily 
evaluated, while PL and PN were not detected. 
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INTRODUCTION 
Natural corticosteroids, as cortisol (F) and cortisone (E), are hormones that are involved in a 
wide range of physiopathological processes, such as stress response, inflammation, immune 
function, hydro-electrolyte balance, reproduction, and behavior. F is secreted by the adrenal 
glands and E, not active hormone, is produced from F by the 11b-hydroxysteroid 
dehydrogenases (11bHSDs). Both naturally-occurring and synthetic corticosteroids are used in 
therapeutic medicine for their anti-inflammatory and immunosuppressive actions. Prednisolone 
(PL), a glucocorticosteroid used as a therapeutic agent in livestock, has also been recently 
found in cow urine as an endogenous product of corticosteroid metabolism. [1]Prednisone 
(PN) can be considered an inactive precursor of PL; therefore, it can be linked to the same 
metabolism. 
Effects of the administration of synthetic corticosteroids on urinary F profile were studied in 
more detailed in humans. [2] On the another hand, only a few studies were undertaken to 
analyze natural corticosteroids in the urine of bovine treated or untreated with synthetic 
corticosteroids. 
[ 
Although the presence of endogenous corticosteroids (F and E) was 
evaluated in the urine of animals only information about the mode of excretion rates was 
reported, without providing reference values.
[5] 
Furthermore, PL, that is administered at a 
low dose (alone or within the protocol containing estrogens and b-agonists), can be 
metabolized by drug metabolizing enzyme (DMEs) that are mostly abundant in liver. The 
basic knowledge about cattle DMEs is still superficial and it has not been established yet 
whether synthetic glucocorticoids interfere with natural corticosteroids' metabolism. For 
example, in humans, it was con-firmed that PL influences the production of F by inhibiting the 
hypotha-lamic pituitary adrenal axis
[6]
 and that the F=E ratio can be used as a marker of 
inhibition of 11bHSD type II produced by a specific drug.
[7] 
On the another hand, 
dexamethasone (DX), a synthetic corticosteroid frequently used as a therapeutic agent, can 
interfere with F formation in bovine cell culture.
[8]
 Therefore, F and E could be considered as 
bio-markers for the activity of therapeutic agents. Moreover, in recent years, several research 
groups evaluated new strategies for the development of indirect assessment methods to 
identify animals treated illicitly with anabolic substances (both anabolic hormones and 
corticosteroids).
[4] 
Therefore, it is reasonable to hypothesize that determination of natural 
corticosteroids in animals treated with synthetic glucocorticosteroids is of great current 
interest. In this context evaluation of natural corticosteroid content in cattle might be 
considered as an important tool that could be used in the screening of glucocorticoid abuse. 
The analysis of corticosteroids (either endogenous and=or exogenous) is very complicated, 
as their metabolism gives a large number of metabolites and because of the low concentrations 
found in urine. The sample 
preparation for screening these compounds in human urine has usually been based on a solid 
phase extraction, followed by an enzymatic hydrolysis and sometimes another extraction for 
better purification.
[2]
 Detection and assay methods for corticosteroids have often been based on 
gas chromato- graphic techniques, occasionally coupled with isotope mass spectrometry.
[9] 
However, the determination of corticosteroids in physiological samples presents some 
difficulties as most of these compounds are thermally labile and their volatility is low. The 
derivatization step prior to GC-MS analysis is difficult to be optimized, especially if the aim is to 
detect a large number of natural and=or synthetic corticosteroids. It is also possible to use 
immunoenzymatic techniques such as ELISA for systematic detection of corticosteroids, but this 
technique had problems with interpreting the results, because of the differences in compounds 
cross-reactivity (e.g., possibility of false positive). [10]Recently methods using liquid 
chromatography mass spectrometry (LC-MS) have been found to be promising techniques for 
solving the problem of corticosteroid analysis. ' Especially, liquid chromatography tandem MS 
(LC-MS=MS) method with electrospray ionization (ESI) in negative mode has proved as sensitive 
and specific although not always available in routine laboratories. LC-MS determination of 
endogenous corticosteroids faced some problems and prerequisites related to the chemical 
structure of the steroids. In fact, urine is particularly rich in different steroidic components, 
which are not always well separated during the chromatographic run. Unfortunately most 
fragment ions observed in their mass spectra are common to different components; therefore, a 
complete specificity is not always possible with co-eluting similar compounds. For these 
reasons the HPLC method must be able to separate in a satisfactory way the components of 
interest. 
Thus far, little attention has been paid on simultaneous determination of endogenous 
corticosteroids in bovine urine by means of single quadru-pole mass detector, due to its lower 
specificity and sensitivity with respect to MS=MS detection, although some methods have been 
previously reported for another type of biological matrices. ' Meanwhile, little information is 
available regarding a reference range about the contents of endogenous corticosteroids in 
bovine urine. Taking into account all these issues, our study was focused on the exploitation of 
the potentiality of the single quad-rupole MS detection in order to develop an alternative reliable 
and useful quantitative method for determination of natural F and E and potentially 
endogenous PL and PN in bovine urine, by a less expensive procedure with respect to the 
LC-MS=MS procedure. 
EXPERIMENTAL Chemicals and Reagents 
F, E, PL, PN, and flumethasone (FL) (as internal standard, IS), meth-anol (LC-MS grade), 
formic acid (98-100%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ultrapure 
water was produced with a Milli-Q system (Millipore, Molsheim, France). Beta-glucuronidase 
from Escherichia coli K 12 (EC 3.2.1.31) in a 50% glycerol solution (pH 6.5) was supplied by 
Roche Diagnostics GmbH (BoehringerManheim, Germany). 
Sample Preparation 
Samples of bovine urine were collected from two bovine species: ten bul-locks (age range 
12—22 mo) and ten cow (age range 36—42 mo). The samples were received in frozen condition and 
were kept frozen (—20° C) until analy-sis. A 2-mL aliquot of filtered urine was diluted with 2.5 
mL of phosphate buffer (0.2 M, pH = 6) and was incubated with 80 mL b-glucuronidase from E. 
coli at 55°C for 2hr. After cooling down to room temperature, 20 mL of I ppm FL as IS was 
added and each sample was extracted using Oasis HLB cartridge (3mL, 60 mg, Waters, 
Milan, Italy) with an extraction vacuum system. The following extraction procedure was 
optimized: the cartridge was conditioned with 3 mL of methanol followed by 3 mL of water. 
The sample was deposited on the column and washed first with 3 mL of 10% methanol and 
then with 1 mL of 2% ammonia in 50% methanol. The elution to recover the corticosteroids of 
interest was performed with 2 mL of methanol. The eluate was evaporated under a stream of 
nitrogen and reconstructed in 150 mL of mobile phase. 
Instrumentation 
The method was developed using a Surveyor Plus LC=MS platform comprised of a Surveyor 
LC Pump and Surveyor MSQ single quadrupole mass spectrometer with electrospray ionization 
(ESI) (Thermo-Fisher Scientific, Waltham, MA, USA). 
HPLC Conditions 
Analytical separations were achieved using a 100 x 2.1 mm Restek Ultra II Allure 
Biphenyl column with 3 micron particles. Binary isocratic profile was developed using water (A) 
and methanol (B) both with 0.05% of formic acid at a flow rate of 200 mL=min in ratio 45:55. A 
sample aliquot (20 mL) was introduced into system by manual loop injection. 
Mass Spectrometry 
A single quadrupole mass spectrometer was interfaced via an ESI probe operated in negative 
ion mode and the operating conditions were opti-mized by flow injection analysis (FIA). A full 
scan and many SIM scans were used for MS parameter optimization. For corticosteroid 
identification, the ion with the highest S=N ratio as quantifier ion and two confirmation ions 
were selected for each substance (Table 1). However, analytical work was done by recording the 
SIM chromatogram corresponding to the quantifier ion and the chromatogram acquired in the 
three-ions selected monitoring mode. Other MS parameters were optimized as follows: probe 
temperature: 450°C, needle voltage: 4keV, dwell time 0.1 s, scan range 280-480 Da, and span for 
SIM events 0.5. Chromatograms were monitored in SIM mode as pseudomolecular ion 
species, formic ion adducts, at [M þ 45]~ in the cases of PL and FL, while specific [(M — H) - 
CH2O]~ ion was used for E and PN determination. Xcalibur software from Thermo was used 
for the data processing. 
Calibration Curve 
A standard stock solution of 1 ppm of corticosteroids was prepared in methanol. Standard 
spiking solutions at concentrations of 1 ppb were prepared by dilution of the stock standard 
solution. The appropriate amount of standard spiking solution was added to 2 mL of urine 
specimens from pooled urine samples with a low content of endogenous corticosteroids to 
prepare five calibration standards at the concentration of added analytes ranging from 2.5 up 
to 20 ppb. The urine samples spiked with standards were processed according the same 
sample preparation procedure described previously. The analysis was performed in triplicate, 
the endogen-ous contents were calculated by extrapolation from the regression lines and the 
results were plotted on a calibration curve for each substance. The equations of calibration 
curves were used to calculate unknown corticosteroids concentration in bovine urine. 
 
TABLE 1    Molecular Mass and Specific Diagnostic Ions (Quantifier Ion in Bold) with ESI 
Parameters of the Targeted Corticosteroids 
 
RESULTS AND DISCUSSION Conditions for HPLC and ESI-MS 
The majority of analytical methods which deals with corticosteroids determinations utilizes triple 
quadrupole mass spectrometers (LC-MS= MS).
[14
,
18
,
19]
 The application of HPLC single quadrupole MS 
technique to the determination of corticosteroids in biological samples has received only limited 
attention.
[1
 
]
 
According to literature, ESI is suitable for glucocorticoids, which can undergo ionization both in 
positive and negative modes.
[20]
 Although the positive ionization mode gave a stronger absolute 
response, the negative ionization was selected due to more specific and more characteristic 
frag-mentation with less background noise. In order to obtain spectra with maximum intensities 
of at least one of the three ions characteristic (M þ formate) , (M — H)_ and [(M — H) — CH2O] 
, an individual optimization of MS parameters, especially cone voltage for each corticosteroid, 
proved to be necessary (Table 1). The quantifications were preferably made on one ion 
(quantifier ion) that did not show interferences due to matrix and expressed the highest S=N 
ratio. For F and PL, it was feasible to use the adduct ion (Mþ formate) for quantification, while 
for PN and E the conditions were adjusted to have as the most intense signal the [ (M — H) — 
CF^O]" ion. When additional confidence is mandatory for analyte identifi-cation, further 
measures such as the inclusion of multiple ion confirmation criteria have been required. In our 
experiments from the same run, it was possible to acquire MS data in the three-ion selected 
monitoring mode and the ion ratios between chosen diagnostic ions were used for confirmation 
purposes. Representative SIM signal profiles of studied corticosteroids and chromatograms 
reporting response of the three selected ions are shown in Figure 1 and mass spectra with 
diagnostic ions of E, F, and FL in Figure 2. As it appears in Figure 2, the ratios between the 
diagnostic ions were very simi-lar in both standard mixtures and real urine samples. The ion ratios 
were within the maximum permitted tolerances according to Commission Decision 
2002=657=EC.
[
 
]
 This type of data acquisition and the fact that each SIM analysis was carried out 
at low mass resolution (0.5 amu peak width) further increased method selectivity. To our knowledge, 
this is the first time that this operation mode was used for qualitative purposes. 
When selecting the mobile phase for LC-MS, attention should be paid to the influence of 
mobile phase on the MS sensitivity. Formic acid, as volatile weak organic acid, generally has 
been used as mobile phase additive for the ESI positive mode, due to favorable protonation of basic 
compounds. However, this has not always turned out to occur regularly, especially in case of 
corticosteroids. On the other hand, formic acid has been very often evaluated for the ability to 
promote negative ion formation in the electro-spray ion source.
[20]
 In our preliminary experiments, 
during FIA processing, it was observed that low contribution of [M — H]~ ion, regardless the cone 
voltage, probe temperature, or needle voltage applied. Therefore, for E and FL, molecular ions 
were omitted from the final method setting. Contemporary, all corticosteroids investigated gave a 
prominent pseudomo-lecular peak with formic acid with the highest response at the fixed 
concen-tration of 0.05% in both organic and water phase. Increasing the concentration of 
formic acid produced a gradual decrease in absolute abundances. The chromatographic 
conditions were carefully optimized to obtain the complete separation of the examined analytes. 
It was of particular impor-tance, bearing in mind the common diagnostic ions for some steroids 
investigated (PL and E, for example). For this purpose the AllureTM Biphenyl stationary phase 
proved to be particularly suitable for our steroid separation. Its unique composition of biphenyl 
groups in sterically favorable position-ing enhances the interactions with steroid fused-ring 
moieties, resulting in better retention and satisfactory selectivity. [22]As for most HPLC 
separa-tions, absolute retention times slightly change from run to run, thus relative retention times 
are used as additional confirmatory help. 
As regards the choice of internal standard, FL was chosen after preliminary experiments (data not 
shown) which demonstrated that it did not interfere within chromatographic profile and that it 
was absent in tested urine samples obtained from untreated subjects. 
 
 
  
FIGURE 1 LC=MS chromatographic profiles of examined corticosteroids obtained with described conditions in SIM 
mode for the quantifier ion (upper traces) and as response for the quantifier and the two qualifier ions (lower traces). 
The total responses of the lower traces can result in lower amounts than upper traces due to the different scanning 
parameters applied; (A) Standard mixture at 10 ppb; and (B) real urine sample with measured 8 ppb for F and 12 ppb 
for E. 
 
FIGURE 1 Continued. 
 
FIGURE 2 MS spectra obtained with three-ion selected monitoring mode, showing the chosen diagnos-tic 
ions used for confirmation purposes; (A) IS (flumethasone) in standard mix (upper) and in cow urine 
(36-mo old) (lower); (B) F in standard mix (upper) and in cow urine (36-mo old) (lower); and (C) 
E in standard mix (upper) and in cow urine (36-mo old) (lower). 
Method Validation 
Calibration Curve and Linearity 
Equal aliquots (in triplicates) of a real pooled urine sample containing the lowest amount of 
F and E, fortified with five different amounts of corticosteroids (ranging from 2.5—20 ppb) 
and a constant amount of IS (10 ppb) were subjected to the described procedure. The 
calibration curve was obtained by reporting Ra versus corticosteroids concentration 
(endogenous content plus added ppb). By extrapolating from the obtained calibration curve the 
real pooled urine resulted to contain 2.5 ppb of F and 2.7 of E, while PL and PN appeared 
undetectable. The coefficients of correlation indicate very good linearity, in the observed 
concentration range (Table 2). The LOQ was considered the lowest value of each calibration 
curve that is the real content of F and E and the first spiked quantity of PL and PN (Table 2). 
 
 
  
Precision 
Both instrumental and method precision were studied. 
Instrumental System Precision. The same solution at concentration of 10 ppb for each 
compound was injected 10 times according to the optimal operative conditions to study 
the repeatability of the instrumental system. Repeatability, expressed as relative standard 
deviations (RSD), was in range 3.8—5.2% for all corticosteroids analyzed. These results 
show a good response repeatability of the LC-MS-ESI system. Further, the intermediate 
precision of the system, again calculated as RSD, was applied to evaluate the variability 
of the responses between two different days. The values were between 9.1 and 14.7% 
which was satisfactory considering the detection system used. 
Method Precision and Intermediate Precision. Intra-day precision of the assay was determined 
by replicate analyses of urine samples (n = 6) fortified with 5 ppb of each compound. 
RSDs were satisfactory for PN (4.9%), E (6.8%), and F (10.5%), while for PL a RSD was 
15.6%. The same samples were used for determination of intermediate precision which 
was obtained from injections in different days. F, E, and PN gave satisfactory RSD values 
(ranging from 8.4% to 11.2%). Again, PL showed a remarkable variety (RSD = 17%), 
which can be explained by the fact that, as the most polar among the corticosteroids 
estimated in this study, had the lowest retention time and interacted with more 
co-eluting interference substances. 
Matrix Effects 
The matrix effect (ME) was examined by comparing the mean peak areas of the 
analytes and the IS between two different series. First series was urine samples 
(containing 2.5 and 2.7 of F and E, respectively) spiked after the extraction with 2.5 ppb 
of PL and PN while second series was refer-ence standards (2.5 ppb of F, PL, and PN and 
2.7 of E) always followed with 10 ppb for the IS. The ME was defined as following: 
ME% = 100 x batch 1=batch 2 and it would indicate the possibility of ionization 
suppression or enhancement for analytes and IS, and an endogenous matrix effect is 
implied if the ratio was less than 85% or more than 115%, [23]Internal standard FL 
showed satisfactory value (105.6%) which was an important datum considering that the 
assessment of matrix effect and assay reliability is critical when similar rather than 
stable isotope-labeled analytes are utilized as internal standards. The results for examined 
compounds are presented in Table 2. Ion suppression was observed for PL which was 
obviously affected by the presence of electrolytes and ionizable co-eluting species. 
Nevertheless, as other validation data, such as sensitivity and linearity, were acceptable 
and indicate good performance of the method developed, this was not considered as a 
drawback for PL accurate determination.  
On the contrary, for two natural corticosteroids (F and E), obtained values indicated 
 
TABLE 2    Validation Results for Targeted Corticosteroids 
negligible absolute matrix effects. This was probably accomplished by introducing 
washing with basic water=methanol mixture before elution of sample during SPE 
procedure. This step minimized specific matrix effects of residual compounds and it 
had been proved as prerogative optimal strategy in endogenous corticosteroids 
determination. Furthermore, as concerns chromatographic conditions, establishing a 
prolonged separation run had brought benefit in the signal -to-noise ratio, minimized ion 
suppression, and improved assay sensitivity. 
Application to Real Bovine Urine Samples 
The present analytical protocol has been routinely applied in our labora-tory for two types 
of bovine urine samples. The samples were analyzed and found not containing any other 
of the monitored steroids than E and F (Table 3). To the best of our knowledge, there 
are no direct data regarding the basal concentration of these steroids in bovine urine in 
literature, and this study was undertaken to set up a simple method suitable to obtain 
infor-mation about their content in different bovine samples. In fact, the sensitivity of 
the assay was adequate for the determination of these corticosteroids. 
The method was applied to some urine samples from subjects with different age and 
gender. From the preliminary results obtained a high varia-bility appears, especially in 
bullocks; it seems that older subjects exhibit lower physiological value intervals for F. As 
F has been considered a chemi-cal marker of stress, these results suggest that younger, 
male animals could be more subjected to this phenomenon. A larger sample number 
will be needed in order to obtain significant reference data.  
TABLE 3    Concentration of Cortisol and Cortisone in Different Type of 
Bovine Urine (ppb, Range, MeaniSD) 
 
 
CONCLUSIONS 
By exploiting the optimal performances of the available single quadru-pole MS 
apparatus, a reliable quantification of F, E, PL, and PN was set up with a procedure less 
expensive than the recently reported ones. Using the proposed method, it would be 
possible to perform a preliminary monitoring of bovine urine samples, in the view of 
clinical and eventual inspection purposes. In fact, the method could find application as 
a non-invasive analytical test for the detection of endogenous corticosteroids, which 
could be considered possible biomarkers of illegal treatment. 
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